DK1559715T3 - N-{2-chlor-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) - ureasalt i krystallinsk form - Google Patents
N-{2-chlor-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) - ureasalt i krystallinsk formInfo
- Publication number
- DK1559715T3 DK1559715T3 DK03756734T DK03756734T DK1559715T3 DK 1559715 T3 DK1559715 T3 DK 1559715T3 DK 03756734 T DK03756734 T DK 03756734T DK 03756734 T DK03756734 T DK 03756734T DK 1559715 T3 DK1559715 T3 DK 1559715T3
- Authority
- DK
- Denmark
- Prior art keywords
- quinolyl
- isoxazolyl
- dimethoxy
- chloro
- oxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002306101 | 2002-10-21 | ||
PCT/JP2003/013439 WO2004035572A1 (ja) | 2002-10-21 | 2003-10-21 | N−{2−クロロ−4−[(6,7−ジメトキシ−4−キノリル)オキシ]フェニル}−n’−(5−メチル−3−イソキサゾリル)ウレアの塩の結晶形 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1559715T3 true DK1559715T3 (da) | 2007-12-27 |
Family
ID=32105192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03756734T DK1559715T3 (da) | 2002-10-21 | 2003-10-21 | N-{2-chlor-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) - ureasalt i krystallinsk form |
Country Status (10)
Country | Link |
---|---|
US (1) | US7166722B2 (ja) |
EP (1) | EP1559715B1 (ja) |
JP (1) | JP3763414B2 (ja) |
AT (1) | ATE374199T1 (ja) |
AU (1) | AU2003301430A1 (ja) |
DE (1) | DE60316590T2 (ja) |
DK (1) | DK1559715T3 (ja) |
ES (1) | ES2294317T3 (ja) |
PT (1) | PT1559715E (ja) |
WO (1) | WO2004035572A1 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797823B1 (en) * | 1999-01-22 | 2004-09-28 | Kirin Beer Kabushiki Kaisha | Quinoline derivatives and quinazoline derivatives |
CA2491191C (en) | 2002-07-15 | 2014-02-04 | Exelixis, Inc. | Receptor-type kinase modulators and methods of use |
ES2466818T3 (es) | 2003-09-26 | 2014-06-11 | Exelixis, Inc. | Moduladores c-Met y métodos de uso |
PT1797037E (pt) * | 2004-09-29 | 2015-03-17 | Bayer Healthcare Llc | Processo para a preparação de 4-{4-[({[4-cloro-3- (trifluorometil)-fenil]-amino}-carbonil)-amino]-fenoxi}-nmetilpiridina- 2-carboxamida |
TW200640443A (en) * | 2005-02-23 | 2006-12-01 | Alcon Inc | Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors |
US9037466B2 (en) * | 2006-03-09 | 2015-05-19 | Nuance Communications, Inc. | Email administration for rendering email on a digital audio player |
NZ594594A (en) | 2009-01-16 | 2013-11-29 | Exelixis Inc | Malate salt of n-(4-{ [6,7-bis(methyloxy)quinolin-4-yl]oxy} phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer |
UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
US7998973B2 (en) * | 2009-11-13 | 2011-08-16 | Aveo Pharmaceuticals, Inc. | Tivozanib and temsirolimus in combination |
AU2011307304C1 (en) | 2010-09-27 | 2016-10-20 | Exelixis, Inc. | Dual inhibitors of MET and VEGF for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases |
TW201309650A (zh) | 2011-02-10 | 2013-03-01 | Exelixis Inc | 製造喹啉化合物之方法及包含該化合物之醫藥組合物 |
CN102532116B (zh) * | 2011-08-09 | 2015-01-21 | 武汉迈德森医药科技有限公司 | 抗肿瘤靶向治疗药物tivozanib的合成方法 |
CN104072492A (zh) * | 2013-11-27 | 2014-10-01 | 苏州摩尔医药有限公司 | 一种抗肿瘤靶向治疗药物Tivozanib的合成方法 |
KR102340311B1 (ko) * | 2016-09-13 | 2021-12-20 | 쿄와 기린 가부시키가이샤 | 의약 조성물 |
EP3876934A4 (en) | 2018-11-05 | 2022-08-03 | Aveo Pharmaceuticals, Inc. | USE OF TIVOZANIB TO TREAT PEOPLE WITH REFRACTORY CANCER |
WO2023096651A1 (en) | 2021-11-26 | 2023-06-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for treating bile duct cancers with tivozanib |
CN114213404A (zh) * | 2021-12-27 | 2022-03-22 | 武汉九州钰民医药科技有限公司 | Vegfr抑制剂替沃扎尼的合成工艺 |
WO2024095127A1 (en) * | 2022-10-31 | 2024-05-10 | Pliva Hrvatska D.O.O. | Solid state forms of tivozanib and process for preparation thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1149085C (zh) | 1997-12-22 | 2004-05-12 | 拜尔有限公司 | 用取代杂环脲抑制raf激酶 |
TWI281915B (en) * | 1999-12-24 | 2007-06-01 | Kirin Brewery | Quinoline and quinazoline derivatives and drugs containing the same |
EP1777218B1 (en) * | 2000-10-20 | 2008-12-31 | Eisai R&D Management Co., Ltd. | Process for the preparation of 4-phenoxy quinoline derivatives |
TWI324154B (ja) * | 2001-04-27 | 2010-05-01 | Kyowa Hakko Kirin Co Ltd | |
AU2003292838A1 (en) * | 2002-12-27 | 2004-07-29 | Kirin Beer Kabushiki Kaisha | Therapeutic agent for wet age-related macular degeneration |
-
2003
- 2003-10-21 PT PT03756734T patent/PT1559715E/pt unknown
- 2003-10-21 DK DK03756734T patent/DK1559715T3/da active
- 2003-10-21 EP EP03756734A patent/EP1559715B1/en not_active Expired - Lifetime
- 2003-10-21 AT AT03756734T patent/ATE374199T1/de not_active IP Right Cessation
- 2003-10-21 WO PCT/JP2003/013439 patent/WO2004035572A1/ja active IP Right Grant
- 2003-10-21 ES ES03756734T patent/ES2294317T3/es not_active Expired - Lifetime
- 2003-10-21 DE DE60316590T patent/DE60316590T2/de not_active Expired - Lifetime
- 2003-10-21 AU AU2003301430A patent/AU2003301430A1/en not_active Abandoned
- 2003-10-21 JP JP2004544999A patent/JP3763414B2/ja not_active Expired - Lifetime
- 2003-10-21 US US10/532,104 patent/US7166722B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2294317T3 (es) | 2008-04-01 |
EP1559715A1 (en) | 2005-08-03 |
PT1559715E (pt) | 2007-10-24 |
US20060052415A1 (en) | 2006-03-09 |
ATE374199T1 (de) | 2007-10-15 |
JP3763414B2 (ja) | 2006-04-05 |
DE60316590T2 (de) | 2008-06-19 |
DE60316590D1 (en) | 2007-11-08 |
EP1559715A4 (en) | 2006-03-29 |
EP1559715B1 (en) | 2007-09-26 |
US7166722B2 (en) | 2007-01-23 |
AU2003301430A1 (en) | 2004-05-04 |
JPWO2004035572A1 (ja) | 2006-02-16 |
WO2004035572A1 (ja) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1559715T3 (da) | N-{2-chlor-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) - ureasalt i krystallinsk form | |
RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
NZ528851A (en) | N-aroyl cyclic amines | |
SE0102300D0 (sv) | Compounds | |
RU99128053A (ru) | Новые циклические соединения диамина и содержащие их лекарственные средства | |
BR9812046A (pt) | Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto | |
NO912410D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater. | |
EA200601846A1 (ru) | Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей | |
NO980848D0 (no) | Piperazinoderivater som neurokininantagonister | |
IT1226727B (it) | Farmaci precursori della dopamina. | |
RU2003103780A (ru) | Соединения фенилпиридазина и содержащие их лекарственные средства | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
DK1465625T3 (da) | Opløste topoisomerase-gifte | |
RU2008127260A (ru) | Производные хиназолинона в качестве антагонистов ваниллоидов | |
DK0397365T3 (da) | Arylthiazolylimidazoler som 5HT3-antagonister | |
ATE137501T1 (de) | Benzazin-verbindungen und deren pharmazeutische verwendungen | |
ES2089974B1 (es) | Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica. | |
ATE141605T1 (de) | Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen | |
ATE137223T1 (de) | Leukotrien-b4-antagonisten | |
NO165195C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. | |
NO872781L (no) | 4-(aroylamino)piperidinbutanamid-derivater. | |
FI964303A0 (fi) | Keuhkosydänvian hoitamiseen tarkoitettu aine | |
MX9304403A (es) | Derivados farmacologicamente activos de ó-(aminometilo terciario)-bencenmetanol | |
ATE44875T1 (de) | 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln. | |
SE9401965D0 (sv) | New compounds |